Pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders; Biotherapeutic pharmaceutical blood preparations for the treatment of hemophilia; Biotherapeutic pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia